BioAge Labs, Inc (BIOA) — Strategic Asset Allocation Index
BioAge Labs, Inc (BIOA) has a Strategic Asset Allocation Index of 16.7% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $62.62 Million) total $62.62 Million, measured against net assets of $374.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is BioAge Labs, Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
BioAge Labs, Inc Strategic Asset Allocation Index (2024–2025)
This chart shows how BioAge Labs, Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 16.7%, representing strategic assets of $62.62 Million against net assets of $374.91 Million USD. For live market cap and overall valuation, see BioAge Labs, Inc stock valuation.
Annual Strategic Asset Allocation Index for BioAge Labs, Inc (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for BioAge Labs, Inc from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See BioAge Labs, Inc (BIOA) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.5% | $4.13 Million | $- | $4.13 Million | $272.05 Million | ▲ +1.5 pp |
| 2024 | 0.0% | $100.00K | $- | $100.00K | $323.13 Million | — |